growth-500

2019 - 376 - BioSyent

Acquires and licenses pharmaceutical products to bring to market in Canada

Growth 500: Canada’s Fastest-Growing Companies

Company Profile

Founded 2006
Chief Executives René Goehrum
Head Office Toronto
Website www.biosyent.com
Stock Ticker TSX-V: RX

 

Company Financials

5-year Revenue Growth (%) 176%
Employees 2018 45
2018 Revenue ($mil) 20-50